Kentucky Attorney General Sues GlaxoSmithKline for False Claims

Kentucky's attorney general has joined in the legal action against GlaxoSmithKline, filing a lawsuit accusing the company of concealing the cardiovascular risks associated with a diabetes drug.
Feb. 22, 2013

Kentucky's attorney general has joined in the flurry of legal action against GlaxoSmithKline, filing a lawsuit accusing the company of concealing the cardiovascular risks associated with a diabetes drug.

The suit claims that GlaxoSmithKline LLC violated the state's Consumer Protection Act by overstating the effectiveness of the prescription drug Avandia and hiding its risks from consumers. Instead of reducing cardiovascular risks faced by diabetics, as the drug maker claimed, the one-time blockbuster drug actually increases those risks, Attorney General Jack Conway said Thursday.

Read the full story

About the Author

Sign up for Pharma Manufacturing Newsletters
Get the latest news and updates